Amgen Inc.

AMGN

US0311621009

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

Pharmaceuticals

Calendar

19/05/2024 - American Thoracic Society Conference - Efficacy and Safety of Avacopan Versus

Related indices

Dow Jones Industrial , S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

278.4 USD

Average target price

304.4 USD

Spread / Average Target

+9.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AMGEN INC.	+8.78%	149B
ELI LILLY AND COMPANY	+26.54%	681B
NOVO NORDISK A/S	+21.85%	556B
JOHNSON & JOHNSON	-4.86%	361B
MERCK & CO., INC.	+17.22%	325B
ABBVIE INC.	+5.32%	285B
ASTRAZENECA PLC	+13.68%	235B
NOVARTIS AG	+3.65%	199B
ROCHE HOLDING AG	-11.12%	189B
PFIZER, INC.	-4.04%	157B

Other Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:29:13 03/05/2024 pm IST			5-day change	1st Jan Change
311.8 ^USD	+12.02%		+16.05%	+8.78%

07:57pm	Slumping Payrolls Push US Equity Indexes Higher as Treasury Yields Sink	MT
07:15pm	News Highlights : Top Company News of the Day - Friday at 1 PM ET	DJ

Slumping Payrolls Push US Equity Indexes Higher as Treasury Yields Sink	11:27pm	MT
News Highlights : Top Company News of the Day - Friday at 1 PM ET	10:45pm	DJ
US Equity Indexes Jump as Slumping Payrolls Instill Life Into Rate Cut Hopes	10:14pm	MT
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	09:49pm	MT
Wall St rallies after soft jobs data allays rate jitters	09:43pm	RE
UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating	09:15pm	MT
Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained	09:11pm	MT
News Highlights : Top Company News of the Day - Friday at 11 AM ET	08:47pm	DJ
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	08:30pm	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Higher Earnings, Weaker Jobs Report	08:27pm	MT
US Jobs Growth Slows in April as US Equity Futures Rise Pre-Bell	08:23pm	MT
Sector Update: Health Care	08:23pm	MT
Wall St opens sharply higher on soft jobs data	07:03pm	RE
News Highlights : Top Company News of the Day - Friday at 9 AM ET	06:46pm	DJ
Wall St set to open sharply higher on soft jobs data	06:28pm	RE
Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug	04:57pm	MT
Apple, Jobs Report Boost Wall Street Pre-Bell; Asia Mixed, Europe Up	04:49pm	MT
News Highlights : Top Company News of the Day - Friday at 7 AM ET	04:47pm	DJ
William Blair Upgrades Amgen to Outperform From Market Perform	04:46pm	MT
Stock Futures Robust Pre-Bell Ahead of April Jobs Report; Asia Churns, Europe Gains	04:44pm	MT
Leerink Adjusts Price Target on Amgen to $352 From $324, Keeps Market Perform Rating	04:25pm	MT
Amgen Q1 Non-GAAP Earnings Decline, Revenue Increases; Adjusts Full-Year Guidance; Shares Advance Premarket	04:11pm	MT
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	04:06pm	RE
Amgen shares jump after teasing weight-loss drug data, rivals slip	03:46pm	RE
North American Morning Briefing : Apple, Amgen -2-	03:39pm	DJ